Annegret Bitzer

Safety and immunogenicity of a single-shot live-attenuated chikungunya vaccine: a double-blind, multicentre, randomised, placebo-controlled, phase 3 trial

Martina Schneider, Marivic Narciso-Abraham, Sandra Hadl et al. · The Lancet · 2023 · 192 citations · Full text

The immunoproteasome: a novel drug target for autoimmune diseases.

Michael Basler, Sarah Mundt, Annegret Bitzer et al. · PubMed · 2015 · 124 citations

Clinical Immunology, Novel Drug Target, Immunodeficiencies +27

Effectiveness of CHIKV vaccine VLA1553 demonstrated by passive transfer of human sera

Pierre Roques, Andrea Fritzer, Nathalie Dereuddre‐Bosquet et al. · JCI Insight · 2022 · 68 citations · Full text

Stable Antigen Is Most Effective for Eliciting CD8⁺T-Cell Responses after DNA Vaccination and Infection with Recombinant Vaccinia Virus<i>In Vivo</i>

Christopher Schliehe, Annegret Bitzer, Maries van den Broek et al. · Journal of Virology · 2012 · 46 citations · Full text

Viral Immunity, Immunology, Antigen Processing +17

Immunoproteasome subunit deficiency has no influence on the canonical pathway of NF-κB activation

Annegret Bitzer, Michael Basler, Daniel Krappmann et al. · Molecular Immunology · 2017 · 37 citations

Inflammation, Cytokine, Molecular Immunology +15